NCT07169851 2026-03-06
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Eli Lilly and Company
Phase 2 Recruiting
Eli Lilly and Company
Adcytherix SAS
Dana-Farber Cancer Institute
Massachusetts General Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shanghai Juncell Therapeutics